Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XFOR |
---|---|---|
09:32 ET | 6062 | 0.8897 |
09:34 ET | 353 | 0.87055 |
09:36 ET | 4375 | 0.87 |
09:38 ET | 4500 | 0.8712 |
09:39 ET | 100 | 0.8712 |
09:41 ET | 12063 | 0.8655 |
09:43 ET | 8505 | 0.87 |
09:45 ET | 3880 | 0.8656 |
09:48 ET | 3951 | 0.855 |
09:50 ET | 1209 | 0.86 |
09:52 ET | 18710 | 0.87 |
09:54 ET | 800 | 0.8755 |
09:56 ET | 1400 | 0.8798 |
10:01 ET | 3300 | 0.875 |
10:03 ET | 3107 | 0.8602 |
10:06 ET | 1700 | 0.8627 |
10:10 ET | 100 | 0.8706 |
10:12 ET | 650 | 0.8623 |
10:14 ET | 10200 | 0.8663 |
10:15 ET | 10199 | 0.8691 |
10:17 ET | 1929 | 0.864 |
10:21 ET | 17300 | 0.86 |
10:24 ET | 3100 | 0.8585 |
10:26 ET | 3100 | 0.8577 |
10:28 ET | 900 | 0.8637 |
10:30 ET | 200 | 0.8639 |
10:32 ET | 14303 | 0.85045 |
10:33 ET | 37301 | 0.8501 |
10:35 ET | 500 | 0.8533 |
10:37 ET | 8891 | 0.8535 |
10:39 ET | 1432 | 0.8535 |
10:42 ET | 11300 | 0.866 |
10:44 ET | 518 | 0.864299 |
10:46 ET | 1100 | 0.8662 |
10:48 ET | 100 | 0.87 |
10:50 ET | 400 | 0.8692 |
10:51 ET | 1300 | 0.8613 |
10:53 ET | 5800 | 0.8613 |
10:55 ET | 7850 | 0.8613 |
10:57 ET | 1000 | 0.8611 |
11:00 ET | 500 | 0.8684 |
11:02 ET | 1600 | 0.8675 |
11:04 ET | 700 | 0.8674 |
11:06 ET | 46000 | 0.8645 |
11:08 ET | 334 | 0.8624 |
11:09 ET | 2100 | 0.8653 |
11:11 ET | 400 | 0.8687 |
11:13 ET | 4500 | 0.8698 |
11:15 ET | 100 | 0.8698 |
11:18 ET | 10200 | 0.864751 |
11:20 ET | 300 | 0.8691 |
11:22 ET | 300 | 0.8691 |
11:24 ET | 300 | 0.87 |
11:26 ET | 150 | 0.868876 |
11:27 ET | 1910 | 0.87 |
11:29 ET | 14691 | 0.87 |
11:31 ET | 1750 | 0.87 |
11:33 ET | 100 | 0.87 |
11:36 ET | 914 | 0.8691 |
11:40 ET | 310 | 0.8668 |
11:42 ET | 500 | 0.8668 |
11:45 ET | 150 | 0.8637 |
11:47 ET | 300 | 0.8668 |
11:51 ET | 100 | 0.8668 |
11:54 ET | 5497 | 0.868 |
11:56 ET | 710 | 0.8693 |
11:58 ET | 200 | 0.8699 |
12:00 ET | 430 | 0.8699 |
12:02 ET | 100 | 0.8699 |
12:03 ET | 200 | 0.8699 |
12:05 ET | 31704 | 0.874 |
12:07 ET | 300 | 0.876 |
12:09 ET | 100 | 0.876 |
12:12 ET | 1102 | 0.876 |
12:14 ET | 2620 | 0.8758 |
12:16 ET | 200 | 0.8774 |
12:18 ET | 800 | 0.8774 |
12:20 ET | 3025 | 0.8759 |
12:21 ET | 700 | 0.876 |
12:23 ET | 1900 | 0.8729 |
12:27 ET | 1200 | 0.8703 |
12:30 ET | 900 | 0.8703 |
12:32 ET | 1379 | 0.8625 |
12:34 ET | 100 | 0.866 |
12:41 ET | 200 | 0.867 |
12:43 ET | 552 | 0.8657 |
12:48 ET | 200 | 0.8631 |
12:50 ET | 100 | 0.8665 |
12:52 ET | 100 | 0.8673 |
12:54 ET | 4056 | 0.8673 |
12:56 ET | 22640 | 0.87 |
12:57 ET | 400 | 0.87 |
12:59 ET | 400 | 0.87 |
01:01 ET | 100 | 0.87 |
01:03 ET | 600 | 0.87 |
01:06 ET | 1700 | 0.87 |
01:08 ET | 1922 | 0.867001 |
01:10 ET | 100 | 0.87 |
01:14 ET | 333 | 0.87 |
01:17 ET | 300 | 0.87 |
01:19 ET | 250 | 0.8699 |
01:21 ET | 22600 | 0.8588 |
01:24 ET | 1000 | 0.8635 |
01:26 ET | 200 | 0.8592 |
01:28 ET | 3930 | 0.8656 |
01:30 ET | 110 | 0.863199 |
01:33 ET | 200 | 0.8649 |
01:35 ET | 500 | 0.8611 |
01:37 ET | 67486 | 0.8599 |
01:39 ET | 4700 | 0.8599 |
01:42 ET | 31574 | 0.8649 |
01:46 ET | 800 | 0.8648 |
01:48 ET | 488 | 0.8649 |
01:50 ET | 300 | 0.8649 |
01:51 ET | 200 | 0.8649 |
01:53 ET | 1100 | 0.8649 |
01:55 ET | 35583 | 0.8667 |
01:57 ET | 300 | 0.8693 |
02:00 ET | 1300 | 0.87 |
02:02 ET | 321 | 0.87 |
02:04 ET | 206 | 0.8699 |
02:06 ET | 1409 | 0.87 |
02:08 ET | 300 | 0.8699 |
02:09 ET | 600 | 0.87 |
02:11 ET | 6881 | 0.8696 |
02:13 ET | 200 | 0.8697 |
02:15 ET | 1180 | 0.8689 |
02:18 ET | 1000 | 0.868 |
02:20 ET | 400 | 0.8675 |
02:22 ET | 2500 | 0.8675 |
02:24 ET | 1500 | 0.8634 |
02:26 ET | 3100 | 0.8673 |
02:27 ET | 1100 | 0.8673 |
02:29 ET | 300 | 0.8673 |
02:31 ET | 740 | 0.8644 |
02:33 ET | 500 | 0.8671 |
02:36 ET | 800 | 0.8661 |
02:38 ET | 10931 | 0.8671 |
02:40 ET | 43014 | 0.87 |
02:42 ET | 48099 | 0.8715 |
02:44 ET | 15821 | 0.8699 |
02:47 ET | 168 | 0.8707 |
02:49 ET | 100 | 0.8707 |
02:51 ET | 3232 | 0.8707 |
02:54 ET | 300 | 0.8667 |
02:56 ET | 2600 | 0.86855 |
02:58 ET | 911 | 0.87 |
03:00 ET | 200 | 0.86955 |
03:02 ET | 1100 | 0.86955 |
03:03 ET | 38909 | 0.8696 |
03:05 ET | 3204 | 0.8668 |
03:09 ET | 200 | 0.8694 |
03:12 ET | 2400 | 0.8668 |
03:14 ET | 1908 | 0.86705 |
03:16 ET | 300 | 0.866 |
03:18 ET | 500 | 0.866 |
03:20 ET | 400 | 0.8675 |
03:21 ET | 1050 | 0.8689 |
03:23 ET | 400 | 0.86745 |
03:25 ET | 600 | 0.8691 |
03:27 ET | 1000 | 0.8689 |
03:30 ET | 1290 | 0.86745 |
03:32 ET | 2450 | 0.867 |
03:34 ET | 1600 | 0.8674 |
03:36 ET | 704 | 0.8657 |
03:38 ET | 800 | 0.8662 |
03:39 ET | 1310 | 0.8662 |
03:41 ET | 600 | 0.8662 |
03:43 ET | 2715 | 0.8676 |
03:45 ET | 5761 | 0.867599 |
03:48 ET | 1828 | 0.86755 |
03:50 ET | 5414 | 0.86775 |
03:52 ET | 51917 | 0.8648 |
03:54 ET | 3127 | 0.8639 |
03:56 ET | 4535 | 0.8631 |
03:57 ET | 78074 | 0.86185 |
03:59 ET | 8543 | 0.862 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
X4 Pharmaceuticals Inc | 145.2M | -1.2x | --- |
PDS Biotechnology Corp | 144.5M | -2.8x | --- |
Compass Therapeutics Inc. | 144.5M | -3.1x | --- |
Corvus Pharmaceuticals Inc | 144.5M | -5.0x | --- |
Cytodyn Inc | 140.6M | -2.6x | --- |
Rani Therapeutics Holdings Inc | 152.7M | -2.3x | --- |
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4, that is being developed as an oral, once-daily therapy. It has developed a pipeline of small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4). It has two pre-clinical candidates: X4P-003, a second-generation CXCR4 antagonist designed to have enhanced properties relative to mavorixafor, potentially enabling opportunities in CXCR4-dependent disorders and primary immunodeficiencies, and X4P-002, a CXCR4 antagonist with a distribution profile and a demonstrated ability to cross the blood-brain barrier.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $145.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 167.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.27 |
EPS | $-0.70 |
Book Value | $0.31 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.